Contents
Academy · Checklists · STROBE (cohort)
The STROBE Cohort Checklist: Where Its Wording Differs from Case-Control and Cross-Sectional
The cohort-specific STROBE checklist shares 22 items with the case-control and cross-sectional variants, but items 6, 12(d), 14(c) and 15 are worded specifically around exposed/unexposed groups, loss to follow-up and outcome events over time.
This is the cohort variant of the STROBE Statement — the checklist for studies in which groups defined by exposure status are followed over time to compare outcome incidence. See the STROBE overview for the shared structure across all three designs.
What it is
von Elm E, Altman DG, Egger M, Pocock SJ, Götzsche PC, Vandenbroucke JP, for the STROBE Initiative, 2007; EQUATOR Network checklist v4, cohort-specific edition.
To give a consistent, agreed set of items for reporting cohort studies — prospective or retrospective — so readers can judge bias, generalisability and validity. The authors state this is solely about reporting clarity, not study design or a quality score.
Cohort studies specifically, both prospective and retrospective/historical, in which participants classified by exposure status are followed to assess one or more outcomes. Not for case-control or cross-sectional designs, which have their own variants.
Is this the right tool?
Use it when
Authors reporting a cohort study, while drafting and at submission to journals requiring STROBE compliance. Researchers designing a cohort study can consult it early so follow-up time and loss-to-follow-up data are actually collected.
Not the right tool when
Case-control or cross-sectional studies should use their own matching STROBE variant — the cohort wording for items 6, 12(d), 14(c) and 15 is built around follow-up concepts (person-time, loss to follow-up) that do not map onto those designs. Not a tool for scoring methodological quality.
The checklist (cohort wording)
22 items; the four that carry cohort-specific wording are marked with an asterisk.
Title through methods
| Item | What it requires |
|---|---|
| 1. Title/abstract | State “cohort study” in the title or abstract; give a balanced summary. |
| 2–3. Introduction | Background/rationale and specific objectives. |
| 4–5. Design and setting | Key design elements up front; setting, locations, recruitment/exposure/follow-up dates. |
| 6*. Participants | Eligibility, selection sources and follow-up methods; matching criteria and exposed/unexposed counts if matched. |
| 7–11. Variables and methods | Outcomes/exposures/confounders defined; data sources; bias efforts; study size; quantitative-variable handling. |
| 12*. Statistical methods | Confounding, subgroups, missing data, sensitivity analyses, and how loss to follow-up was addressed. |
Results, discussion, funding
| Item | What it requires |
|---|---|
| 13. Participants | Numbers at each stage, separately for exposed and unexposed, ideally with a flow diagram. |
| 14*. Descriptive data | Characteristics by exposure group, missing data, and follow-up time summarised (average/total). |
| 15*. Outcome data | Outcome events or summary measures over time, separately by exposure group. |
| 16–17. Main and other results | Adjusted/unadjusted estimates with precision; subgroup/sensitivity analyses. |
| 18–22. Discussion and funding | Key results, limitations/bias direction, interpretation, generalisability, funding. |
Applying it, with the evidence
Two Iranian audits a few years apart give a before/after picture. In a 2009 review of 60 cohort studies published before STROBE existed, a participant flow diagram (now item 13c) appeared in only 30% of papers. In a 2011 review of 60 cohort studies published after STROBE, 23.6% of applicable items were still unreported, and items such as efforts to address bias and the flow diagram were each missing in 85% of papers. A larger review of 37 CKD cohort studies found the item that improved most after STROBE was reporting losses to follow-up (0% before vs 36% after) — exactly what a reader needs to judge whether attrition biased the results.
The cohort checklist is heaviest used in clinical epidemiology, nephrology and CKD research, oncology risk-factor studies, cardiovascular and diabetes longitudinal research, and allergy/immunology — fields built on prospective or retrospective follow-up of a defined population tracking incidence, mortality or progression.
In order
Where it goes right
With it — no verifiable example found
Our research for this page did not turn up a named, checkable published paper that explicitly credits this checklist for a well-reported study. Rather than invent one, we are saying so. If you know of one, the EQUATOR Network page for this guideline is the place such examples tend to get collected.
Common mistakes
- Loss to follow-up and total follow-up time are the most under-reported items. Both are central to judging attrition bias.
- Report outcomes “over time,” not just a final total. Item 15 asks for incidence or person-time, not a single aggregate count.
- Do not collapse exposed/unexposed into one row. Items 13 and 14 need to be reported separately by exposure group.
Where it falls short
Without it — two cohort-specific audits, 2011 and 2016
Reviewing 60 post-STROBE cohort studies, Poorolajal et al. found 23.6% of applicable sub-items unreported overall; efforts to address bias and the flow diagram were each missing in 85% of studies, sensitivity analyses in 73.3%. Separately, Rao et al. reviewed 37 pre-dialysis CKD cohort studies before and after STROBE and found reporting of losses to follow-up rose from 0% to only 36%, while the underlying study-design quality (Newcastle-Ottawa Scale) showed no improvement at all — STROBE improved what authors wrote, not necessarily how rigorously the studies were designed.
Poorolajal J, Cheraghi Z, Doosti Irani A, Rezaeian S. “Quality of Cohort Studies Reporting Post the STROBE Statement.” Epidemiology and Health, 2011;33:e2011005; and Rao A, Brück K, Methven S, et al. “Quality of Reporting and Study Design of CKD Cohort Studies Assessing Mortality in the Elderly Before and After STROBE.” PLoS ONE, 2016;11(5):e0155078. doi.org/10.1371/journal.pone.0155078.
Common questions
The cohort version asks for eligibility, selection sources and follow-up methods; case-control asks for case ascertainment and control selection instead.
Over time — incidence across the follow-up period, not a single cumulative total.
Yes — both prospective and retrospective/historical cohorts, since the defining feature is the exposure-to-outcome cohort structure, not when follow-up occurred.
References and sources
- von Elm E, Altman DG, Egger M, et al., for the STROBE Initiative. The STROBE Statement: guidelines for reporting observational studies — cohort studies. Annals of Internal Medicine 2007;147(8):573–577. read 8 October 2026. doi.org/10.7326/0003-4819-147-8-200710160-00010
- EQUATOR Network. STROBE checklist, cohort studies (v4). read 8 October 2026. equator-network.org
Each source carries the date it was last read. Where a standard moves, this article is revised rather than left up with a note.
How to cite this article
Pick your referencing style and copy it. Your university or target journal may vary the punctuation — check its guide if it has one.
Pubrica Academy. (2026, October 8). The STROBE Cohort Checklist: Where Its Wording Differs from Case-Control and Cross-Sectional. Pubrica. https://pubrica.com/insights/checklist/strobe-cohort-study-checklist/
Pubrica Academy. “The STROBE Cohort Checklist: Where Its Wording Differs from Case-Control and Cross-Sectional.” Pubrica, 8 Oct. 2026, pubrica.com/insights/checklist/strobe-cohort-study-checklist/.
Pubrica Academy (2026) The STROBE Cohort Checklist: Where Its Wording Differs from Case-Control and Cross-Sectional. Pubrica. Available at: https://pubrica.com/insights/checklist/strobe-cohort-study-checklist/ (Accessed: 15 October 2026).
Pubrica Academy. “The STROBE Cohort Checklist: Where Its Wording Differs from Case-Control and Cross-Sectional.” Pubrica. October 8, 2026. https://pubrica.com/insights/checklist/strobe-cohort-study-checklist/
Pubrica Academy, ‘The STROBE Cohort Checklist: Where Its Wording Differs from Case-Control and Cross-Sectional’ (Pubrica, 8 October 2026) <https://pubrica.com/insights/checklist/strobe-cohort-study-checklist/> accessed 15 October 2026.
Pubrica Academy. The STROBE Cohort Checklist: Where Its Wording Differs from Case-Control and Cross-Sectional. [Internet]. Pubrica; 2026 Oct 8 [cited 2026 Oct 15]. Available from: https://pubrica.com/insights/checklist/strobe-cohort-study-checklist/
Pubrica Academy, “The STROBE Cohort Checklist: Where Its Wording Differs from Case-Control and Cross-Sectional,” Pubrica, Oct. 8, 2026. [Online]. Available: https://pubrica.com/insights/checklist/strobe-cohort-study-checklist/
@misc{strobe_cohort_study_checklist_2026,
author = {{Pubrica Academy}},
title = {The STROBE Cohort Checklist: Where Its Wording Differs from Case-Control and Cross-Sectional},
howpublished = {Pubrica},
year = {2026},
month = {oct},
url = {https://pubrica.com/insights/checklist/strobe-cohort-study-checklist/},
note = {Accessed: <span data-cite-acc="iso">2026-10-15</span>}
}This article is written to be learned from. Cite it if you are referring to what it says; if you are using the evidence behind it, cite the sources listed above instead.
Pubrica AcademyWritten and maintained by the subject matter experts of Pubrica who do this work. Articles are revised when the standard underneath them moves, and each one carries the date it was last checked.
How Pubrica helps
Pubrica’s biostatistics team builds the cohort-specific items — follow-up time, loss to follow-up, exposure-group reporting — around your actual dataset before the manuscript is drafted.